Report - CHMP extension of indication variation assessment report · Procedure No. EMEA/H/C/000701/II/0097 . Marketing authorisation holder (MAH): Bristol-Myers Squibb Pharma EEIG . CHMP extension

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form